The price of Genentech stock went up yesterday afternoon, closing at $83.14 after climbing 1.9 percent. Perhaps we already are seeing a pharma comeback as the Pfizer-Wyeth merger progresses, and perhaps Genentech stock prices will continue to rise until Roche--or someone else--makes it an offer it cannot refuse. Report.